Capital Markets Trading Uk LLP Bausch Health Companies Inc. Transaction History

Capital Markets Trading Uk LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $203,256 - $343,136	-10,760 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $821,168 - $1.01 Million	-39,328 Reduced 78.52%	10,760 $235,000
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $1.03 Million - $1.32 Million	50,088 New	50,088 $1.26 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $775,840 - $1.01 Million	-38,351 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $712,991 - $1.14 Million	-40,419 Reduced 51.31%	38,351 $708,000
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $1.63 Million - $2.02 Million	78,770 New	78,770 $2.02 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Capital Markets Trading Uk LLP, based on Form 13F filings with the SEC.

Stay updated on Capital Markets Trading Uk LLP with notifications on news.